Clinical Trial Update: Effect of Adiponectin Genetic Polymorphism on Rosiglitazone Response

View source ↗

Summary

This completed clinical trial examines whether adiponectin genetic polymorphisms influence response to rosiglitazone in diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Rosiglitazone (rosiglitazone)

Snippet

Sponsor: Central South University | Conditions: Diabetes Mellitus | Status: COMPLETED